OCUL Q1 2026 Earnings WiderThanExpected Loss as Ocular Therapeutix Advances Pipeline Silvercrest Asset Management Group Inc Q1 2026 Earnings EPS Misses Estimates Stock Declines Fortrea Holdings Inc FTRE Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction JPM Q1 2026 Earnings EPS Beats Estimates by Nearly 8 as Strong Trading and Investment Banking Results Drive Performance Acrivon Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as clinical development progresses BCRX Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction